Qiagen N.V. (LON:0RLT)

Market Cap	7.65B
Revenue (ttm)	1.54B
Net Income (ttm)	301.57M
Shares Out	n/a
EPS (ttm)	1.37
PE Ratio	25.35
Forward PE	19.32
Dividend	1.20 (2.95%)
Ex-Dividend Date	Jul 2, 2025

Volume	34,844
Average Volume	80,557
Open	40.18
Previous Close	40.52
Day's Range	39.77 - 40.66
52-Week Range	34.39 - 51.23
Beta	0.67
RSI	47.98
Earnings Date	Feb 1, 2026

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,396
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RLT

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD